# A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo to Reduce the Need for Blood Transfusions and Reduce the Occurrence of Severe Anemia During the Time Period Surrounding Total Hip Replacement Surgery

> **NCT00269958** · PHASE2 · COMPLETED · sponsor: **Janssen-Ortho Inc., Canada** · enrollment: 208 (actual)

## Conditions studied

- Anemia

## Interventions

- **DRUG:** epoetin alfa

## Key facts

- **NCT ID:** NCT00269958
- **Lead sponsor:** Janssen-Ortho Inc., Canada
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 1991-12
- **Target enrollment:** 208 (ACTUAL)
- **Last updated:** 2011-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00269958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00269958, "A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo to Reduce the Need for Blood Transfusions and Reduce the Occurrence of Severe Anemia During the Time Period Surrounding Total Hip Replacement Surgery". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00269958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*